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A B S T R A C T
Natural plant products have been used for centuries for health maintenance and treat-
ment of a variety of diseases in various traditional systems of medicine in Egypt and other
African countries, India, China, and other countries around the world. Over the past several
decades, the popularity of herbal and other natural products has gradually increased in many
western countries. Despite the increasing popularity of natural products, both the public
and the professionals are skeptical about the use of these products. Reasons for this skep-
ticism include, but are not limited to, the lack of proper documentation about the source
and formulations used; standardization of the composition, batch-to-batch consistency, docu-
mented safety of herbal products; and information about the mechanisms of action of these
products. The 1st Euro-MediterraneanWorkshop: Natural Products in Health and Diseases was or-
ganized by the Euro-Mediterranean Association of Life Sciences (EMALS) and various other
local organizations to review and discuss the above-mentioned strengths and limitations
of the use of natural products. The aim of this workshop was to share best practices and
expertise about natural products, and to identify opportunities for collaboration among re-
searchers, health professionals, and business personnel in a productive atmosphere.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical
University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
For thousands of years, natural products have played a very
important role in health care and prevention of diseases. The
ancient civilizations of the Chinese, Indians and North Afri-
cans provide written evidence for the use of products from
natural sources for curing various diseases [1]. The earliest
knownwritten document is a 4000-year-old Sumerian clay tablet
that records remedies for various illnesses [2]. For example,
mandrake was used for pain relief, turmeric for blood clot-
ting properties, roots of the endive plant for gall bladder
disorders, and raw garlic for circulatory disorders.These agents
are still being used in several countries as alternative medicines.
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According to recent studies conducted by theWorld Health
Organization (WHO), about 80% of the world’s population relies
on traditional medicine [3]. About 121 drugs prescribed in the
USA today are from natural sources, 90 of which are derived
either directly or indirectly from plant sources [4]. Further-
more, forty-seven percent of the anticancer drugs in the market
are from natural products or natural product mimics [4].
It is well documented that most natural products are en-
riched with bioactive components that have protective action
against potentially disease-inducing events. There is cur-
rently a growingbodyof evidence that supplementing thehuman
dietwithnatural products offersmajor benefits forhumanhealth
and well-being. The use of complementary/alternative medi-
cine, functional foods, and other natural products has been
increasing rapidly worldwide, mostly because of the per-
ceived safety of such products.The issues regarding the efficacy
and safety of currently availablemodern (allopathic) drugs have
prompted the search for safer andmore effective alternatives.
As elaborated below, this workshop was focused on the use of
natural products for health and disease prevention.
The aim of the 1st BioNat International Workshop was to
share best practices and expertise, and to identify opportuni-
ties for collaboration. Well-known researchers, health
professionals, and business personnel presented their exper-
tise in a productive atmosphere. It was organized by the Euro-
MediterraneanAssociation of Life Sciences (EMALS) and various
other local organizations. EMALS aims to contribute effec-
tively to the development of international and national
programs of scientific research; to provide strategic services
that affect the lives of scientists, biomedical researchers and
their assistants; to develop their professional and research com-
petence; and to enlist their participation in increasing the
awareness of various segments of the society about science
in general and natural products in particular.
The above-mentioned BioNat workshop considered a range
of issues, such as (1) classification and distribution of wild me-
dicinal plants in Egypt; (2) separation and identification of
bioactive compounds from plants; (3) natural products in the
prevention and treatment of human diseases; (4) antimicro-
bial activity of natural products; (5) search for microbial sources
of natural and unnatural products; (6) natural products chem-
istry, chemosystematics and quality control; and (7) patentability
in pharmacognosy, plant extraction and dietary supplements.
To begin with, Dr. Ashraf A Khalil introduced the speak-
ers, presented a brief synopsis of the importance of the
workshop and discussed the day’s program in detail. During
the period of this workshop, the participants met with expe-
rienced professionals from diverse disciplines, but all connected
with natural products research and applications. Thus, pro-
fessors, project leaders of R&D, post-doc researchers, CEOs,
technical managers, heads of departments, group leaders, PhD
students, and research scientists from both developed and de-
veloping countries were brought together on this occasion to
share current knowledge and future strategies for the use of
medicinal and herbal products for the prevention and treat-
ment of human diseases.
The format of the workshop consisted of lectures and dis-
cussions aimed at reviewing and exchanging basic information
about herbal products and their use in different diseases, and
sharing information via a questionnaire completed by the par-
ticipants. The titles of lectures, the names of the presenters,
and the abstracts summarizing the major findings are given
below. A copy of the questionnaire is also enclosed. The re-
sponses to questions were read, analyzed, and utilized to guide
the discussions within and between lectures.
2. Presentations
2.1. Nanoencapsulation of natural products for their
enhanced anti-cancer activity
The introductory lecture was presented by Prof. Hasan Mukhtar
(School of Medicine and Public Health, Department of Derma-
tology, University of Wisconsin, Madison, WI, USA). He
enlightened the participants with the information that the prac-
tical applicability of the bioactive food components for the
prevention and treatment of human cancer has met with
limited success largely due to inefficient systemic delivery and
bioavailability of promising agents despite highly encourag-
ing results in preclinical settings. His group was the first to
employ nanotechnology to improve the outcome of cancer
chemoprevention by natural agents and to introduce the
concept of, as well as the term, Nanochemoprevention [5].
To establish the proof-of-principle, they encapsulated
epigallocatechin-3-gallate (EGCG) in PLA-PEG nanoparticles (NPs)
and demonstrated a ten-fold dose advantage over native EGCG
in human prostate cancer (PCa) cells both in vitro and in vivo.
Later, they reported the efficacy assessment of a
nanotechnology-based oral formulation of chitosan NPs en-
capsulating EGCG in a PCa tumor xenograft mouse model. Prof.
Mukhtar’s lab demonstrated that nanoformulated EGCG sig-
nificantly induced apoptosis and reduced the expression of
markers of cell proliferation in the tumors [6]. Recently, they
proposed targeted NPs as novel prototypes for the delivery of
EGCG, thereby exploiting small molecular entities able to bind
to prostate-specific membrane antigen (PSMA). PSMA-specific
cellular binding and uptake of the nanosystems were de-
tected, and EGCG polymeric NPs showed an increased anti-
proliferative activity in both PSMA-negative and PSMA-
positive PCa cells, with better efficacy in PSMA-positive cells.
The study revealed a better response to targeted NPs in in-
hibiting the tumor growth as compared to non-targeted EGCG.
In a parallel study, the team of Prof. Mukhtar tested the effi-
cacy of EGCG encapsulated in chitosan NPs and surface-
functionalized withA10 2′-fluoropyrimidine RNA aptamers (chit-
EGCG-Apt) that recognize the extracellular domain of PSMA.
They detected PSMA-specific internalization and accumula-
tion along with a sustained and constant release of EGCG from
the nanobioconjugates. Chit-EGCG-Apt also led to a PSMA-
specific enhanced anti-proliferative activity in PCa cells with
a significant decrease in IC50. EGCG encapsulated in chit-EGCG-
Apt also retained its mechanistic identity for induction of
apoptosis, modulation of cell cycle, and inhibition of inva-
sion and migration. They also designed novel polymeric NPs
composed of PLGA-PEG-COOH encapsulating resveratrol (nano-
RSV) to enhance its bioavailability and to improve the
intracellular penetration. These NPs were able to control the
RSV release at both acidic and physiological conditions. Fluo-
rescence microscopy revealed that NPs were efficiently taken
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up by all PCa cell lines. Furthermore, nano-RSV significantly
improved the cytotoxicity compared to that of free RSV toward
PCa cells proving a consistent sensitivity toward both the
androgen-independent and hormone-sensitive cells. Prof.
Mukhtar ended his lecture with a note that additional work
is required to make this approach useful in preventing and/
or treating cancer in the human population.
2.2. Anti-arthritic activity of traditional medicine herbal
products
The second keynote lecture was presented by Prof. Kamal D.
Moudgil (University of Maryland School of Medicine, Balti-
more, USA). He started his talk by introducing adjuvant arthritis
(AA) as an experimental model of human rheumatoid arthri-
tis (RA) [7]. This model has extensively been used by his group
and many other investigators for testing potential anti-
arthritic agents, including herbal products. AA shares several
features with RA.The disease is inducible in Lewis rats by sub-
cutaneous injection of heat-killed Mycobacterium tuberculosis
H37Ra (Mtb). Arthritis appears within about 10 d of Mtb injec-
tion, peaks about 18 d, and then gradually regresses in the next
7–10 d [7]. Prof. Moudgil and colleagues have tested a multi-
herbal traditional Chinese medicine (TCM) formula, Huo-luo-
xiao-ling (HLXL) dan, in the AAmodel to determine its arthritis-
suppressive effects as well as the immunological and
biochemical mechanisms involved [7,8]. HLXL consists of 11
defined herbs.This herbal extract was characterized by HPLC-
MS using defined compounds as biomarkers [7,8]. The herbal
mixture was also subjected to quality control and toxicity
testing. The feeding of arthritic Lewis rats with HLXL (2.3 g/
rat/d) by gavage was begun at the onset of AA and then
continued throughout the course of disease. Arthritis sever-
ity was graded on a scale from 0 to 4 per paw. The draining
lymph node cells of rats were subjected to immunological tests
to measure the production of cytokines, whereas serum was
tested for levels of antigen-specific antibodies and nitric oxide
(NO).Also tested wasmetalloproteinase-9 (MMP-9) activity. HLXL
reduced the severity of AA, altered the balance between pro-
inflammatory and anti-inflammatory cytokines in favor of the
latter, and reduced NO and MMP-9. Through this prototypic
study, they not only highlighted the importance of TCM for ar-
thritis therapy, but also emphasized the significance of product
characterization, quality control, toxicity assessment, and
mechanistic studies to offer scientific validation of the use of
herbal products for the treatment of autoimmune diseases. Prof.
Moudgil emphasized that using state-of-the-art scientific
methods in natural products research is essential to gain the
confidence of the public as well as the professionals in even-
tual application of natural products as therapeutic agents for
human diseases.
2.3. Classification and distribution of wild medicinal
plants in Egypt
The third lecture was presented by Dr.MonaMohamedMarzouk
(Department of Phytochemistry and Plant Systematic, Na-
tional Research Centre, Cairo, Egypt). Egypt has always been
one of the most important countries in the field of exporta-
tion of medicinal plants. More than one thousand species of
medicinal and aromatic plants are growing in Egypt, which
create a base of raw natural materials for the folkloric medi-
cine, the pharmaceutical industry, and for phytochemical
research.The large numbers and variability of medicinal plants
and their importance in the field of folk medicine in Egypt en-
courage chemists to investigate their chemical and biological
constituents. Medicinal plants are classified in many ways, for
example, according to their life period (annual, biennial or pe-
rennial), their life form (tree, shrub or herb), their usage
(medicinal, culinary, aromatic, or ornamental), or their active
constituents (aromatic; containing volatile oils, astringents; con-
taining tannins, bitter; containing phenol compounds, saponins,
and alkaloids, mucilaginous; containing polysaccharides and
nutritive). Dr. Marzouk explored the principles of Taxonomy of
Medicinal Plants, which involve three steps, namely plant iden-
tification (the identification of an unknown plant by a
professional taxonomist using identification reference books
and by comparison with previously collected specimens), plant
nomenclature (once a plant specimen has been identified, its
name and properties are registered: family, genus and species)
and plant classification (it is the placement of known plants into
groups or categories to show some relationship within the plant
kingdom). Finally, Dr.Marzouk discussed the distribution of wild
medicinal plants in Egypt. The Egyptian flora is composed of
many common species that cover most of the area and also
many rare species that have limited distribution. Over 1000 me-
dicinal species belonging to 340 genera and 78 families are
growing wild in Egypt. Most of these plants are belonging to
the families Compositae, Labiatae, Brassicaceae, Leguminosae,
Umbelliferae, Roseaceae, Rutaceae, Solanaceae, Liliaceae,
Caryophyllaceae, Boraginaceae, Ranunculaceae, Papaveraceae,
Malvaceae, Cucurbitaceae, Verbenaceae, Scrophulariceae and
Plantaginaceae. Mediterranean coastal district (350 species), Nile
region (189 species), North Sinai (141 species) and South Sinai
(132 species, including 12 endemic species) possess the highest
number of species, while Eastern desert (70 species),Western
desert (57 species) and Oasis (46 species) have relatively lesser
number of species.
2.4. Separation and identification of plant phenolics
The fourth lecture was presented by Nesrine M. Hegazi (Re-
searcher of Phytochemistry, National Research Center). Plant
phenolics share a common structural feature: an aromatic ring
bearing at least one hydroxyl substituent. Several classes of
natural products are therefore considered as phenolics, in-
cluding phenolic acids and phenyl propanoids, flavonoids,
tannins, coumarins, lignans and stilbenes. Phenolic metabo-
lites are extracted from the plant material with solvent
extraction, soxhlet extraction or maceration. Newly devel-
oped methodologies include ultrasound-assisted extractions,
pressurized liquid extraction, supercritical fluid extraction and
microwave-assisted extraction. Fractionation and purifica-
tion of the extracts thus obtained are achieved by column
chromatography and/or liquid–liquid extraction. For separa-
tion and detection of the phenolic metabolites, paper
chromatography, thin layer chromatography, gas chromatog-
raphy or high performance liquid chromatography is performed.
Identification and structure elucidation involve conventional
chemical methods and the more advanced spectral
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techniques (mass spectrometry, UV spectrophotometry, and
NMR spectroscopy).
2.5. Patentability in pharmacognosy, plant extraction and
dietary supplements
Dr. Saly Odah (Egyptian Innovation Office, The Egyptian
Academy of Science andTechnology, Cairo, Egypt) gave a com-
prehensive presentation covering practical (patentability) aspects
of natural products research. Dr. Odah overviewed and ex-
plained in details the following topics: (1) What is a patent?
(2)Why should I apply for a patent? (3) Benefits of a patent ap-
plication, (4) What happens if I do not apply? (5) What does a
patent application include? (6) Types of pharmaceutical ap-
plications, (7) Discussion of each type of pharmaceutical
application in detail, and (8) Case studies.
3. Questionnaire
The questionnaire (Table 1) addressed two important aspects
of natural products research: (I) research aspect of natural prod-
ucts, and (II) practical use of natural products. In regard to
research aspects,majority of participants had used one or more
natural products in their research work.These products varied
from crude/purified plant extract to isolated single/multiple
bioactive components of medicinal plants.To name some, green
tea polyphenolic extract, EGCG, pomegranate, Huo-luo-xiao-
ling (HLXL) dan, Celastrus, Celastrol, Naja haje crude venom,
Jojoba,Moringa,Morus alba, Berberine, triterpenoids from plants,
flavonoids from plants, phenolics from L. nobilis, Punica grana-
tum, and other plants, essential oils, and polysaccharides from
plants and algae. Participants emphasized upon several diffi-
culties that they had faced in doing research with a natural
product. For question 3, the choices in descending order ranked
as follows: b, a, c, and e. (Choice ‘d’ was configured into other
choices when analyzing results.) These corresponded to dif-
ficulties in maintaining batch-to-batch consistency (quality
control), obtaining and/or characterizing it, and publishing the
results using natural products, and others. The last category
included two items: difficulty in getting research grants funded,
in part because some reviewers do not believe in the results
obtained with, or the efficacy of, natural products; and diffi-
culty in scaling up the separation techniques economically.
For question 4, participants’ responses brought out some of
the major limitations that are presently hindering their re-
search work. Different participants specifically identified the
lack of the following facilities and other resources: HPLC/MS,
NMR, biological assays, cell culture for anti-cancer effects, es-
tablishing product quality and composition, obtaining a reliable
product for research, characterization of the separated com-
ponents to be used in assays, and limited amount of isolated
compounds such that the amount is not enough for analysis
and biological testing despite best effort invested in purifica-
tion of compounds from natural sources. Accordingly,
appropriate resources in the form of proper instrumentation
and methodology are required to advance the field of natural
products research.
In regard to part II of the questionnaire pertaining to the
practical use of natural products, over half of the partici-
pants shared that they had used a natural product for treatment
of common ailments or any other disease. This included pre-
scribed folk medicine as well as self-procured natural products.
The biological activities of natural products, either extracts or
purified compounds, included anti-inflammatory, anti-microbial,
anti-viral, anti-cancer, and anti-hyperlipidemic effects. Some
of the products named were green tea, pomegranate,Morus alba,
berberine, and snake venom.Among the participants who had
not used a natural product, there was no indication of a bias
against natural products use. Instead, one participant posi-
tively emphasized trust in using natural products. In question
4, participants were also asked to name a few advantages/
positives and a few disadvantages/negatives of using natural
products over allopathic remedies for therapy. Both advan-
tages and disadvantages were identified. The advantages
mentioned were as follows: fewer side effects, high anti-
oxidant contents, organic in nature, biodegradability in the body,
and less expensive, which is a critical consideration in the de-
veloping countries. The disadvantages mentioned were short
preservation time or shelf-life, inadequate marketing, lack of
information about their mechanism of action, not clear whether
the observed effect might be a placebo effect, and being less
effective than synthetic compounds.
R E F E R E N C E S
[1] Phillipson JD. Phytochemistry and medicinal plants.
Phytochemistry 2001;56:237–243.
[2] Kong JM, Goh NK, Chia LS, et al. Recent advances in
traditional plant drugs and orchids. Acta Pharmacol Sin
2003;24:7–21.
Table 1 – Workshop’s surveys.
I. Research aspect of natural products
Q1. Have you used a natural product in your research work?
– If yes, answer questions 2, 3 and 4
– If no, do you have plans to use one in the near future? You
would respond to questions 2, 3 and 4 as you feel preferable.
Q2. Name the product(s) and its source (prepared in the lab; or
commercial; or other)
Q3.What difficulties have you faced in doing research with a natural
product?
– (a) In obtaining and/or characterizing it
– (b) In maintaining batch-to-batch consistency (quality control)
– (c) In publishing the results using natural products
– (d) All of the above
– (e) Others, Please specify
Q4.What type of help from an outside agency/institution would facilitate
your research work on natural products?
II. Practical use of natural products
Q1. Have you used a natural product for treatment of common ailments
or any other disease?
Q2. If yes, name the product and the source (self-procured,
prescribed, etc.)? (You need not to disclose any confidential
information that you are not comfortable with.)
Q3. If no, do you have any bias against using natural products? If
yes, mention the reason(s).
Q4. In your mind, name a few advantages/positives and a few
disadvantages/negatives of using natural products over
conventionally used (allopathic) remedies for therapy.
295a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 2 9 2 – 2 9 6
[3] Benowitz S. As war on cancer hits 25-year mark, scientists
see progress, challenges. Scientist 1996;10:1–7.
[4] Newman DJ, Cragg GM. Natural products as sources of new
drugs over the last 25 years. J Nat Prod 2007;70:461–477.
[5] Siddiqui IA, Adhami VM, Bharali DJ, et al. Introducing
nanochemoprevention as a novel approach for cancer
control: proof of principle with green tea polyphenol
epigallocatechin-3-gallate. Cancer Res 2009;69:1712–1716.
[6] Khan N, Bharali DJ, Adhami VM, et al. Oral administration of
naturally occurring chitosan-based nanoformulated green tea
polyphenol EGCG effectively inhibits prostate cancer cell
growth in a xenograft model. Carcinogenesis 2014;35:415–423.
[7] Yang YH, Rajaiah R, Lee DY, et al. Suppression of ongoing
experimental arthritis by a Chinese herbal formula (huo-luo-
xiao-ling dan) involves changes in antigen-induced
immunological and biochemical mediators of inflammation.
Evid Based Complement Alternat Med 2011;2011:642027.
[8] Zhang RX, Fan AY, Zhou AN, et al. Extract of the Chinese
herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant
arthritis in rats. J Ethnopharmacol 2009;121:366–371.
296 a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 2 9 2 – 2 9 6
